785
Views
60
CrossRef citations to date
0
Altmetric
CRITICAL CARE

Phencyclidine analog use in Sweden—intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project

, &
Pages 856-864 | Received 11 Jun 2015, Accepted 29 Jul 2015, Published online: 21 Aug 2015

References

  • EMCDDA. New psychoactive substances in Europe. An update from the EU Early Warning System (March 2015). 2015. Available at: http://www.emcdda.europa.eu/attachements.cfm/att_235958_EN_TD0415135ENN.pdf.
  • The Public Health Agency of Sweden. Information about the Swedish legislative action on drugs [in Swedish]. Available at: http://www.folkhalsomyndigheten.se/amnesomraden/tillsyn-och-regelverk/klassificering-av-missbrukssubstanser/. (Accessed on June, 2015)
  • Bäckberg M, Lindeman E, Beck O, Helander A. Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project. Clin Toxicol (Phila) 2015;53:46–53.
  • Helander A, Bäckberg M, Hultén P, Al-Saffar Y, Beck O. Detection of new psychoactive substance use among emergency room patients: Results from the Swedish STRIDA project. Forensic Sci Int 2014;243:23–29.
  • Berger ML, Schweifer A, Rebernik P, Hammerschmidt F. NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl)piperidine enantiomers and of related compounds. Bioorg Med Chem 2009;17:3456–3462.
  • Wallach J, De Paoli G, Adejare A, Brandt SD. Preparation and analytical characterization of 1-(1-phenylcyclohexyl)piperidine (PCP) and 1-(1-phenylcyclohexyl)pyrrolidine (PCPy) analogues. Drug Test Anal 2014;6:633–650.
  • Garey RE. PCP (phencyclidine): an update. J Psychedelic Drugs 1979;11:265–275.
  • Anis NA, Berry SC, Burton NR, Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol 1983;79:565–575.
  • Helander A, Beck O, Bäckberg M. Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine. Clin Toxicol (Phila) 2015;53:446–453.
  • Morris H, Wallach J. From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Test Anal 2014;6:614–632.
  • Misselbrook GP, Hamilton EJ. Out with the old, in with the new? Case reports of the clinical features and acute management of two novel designer drugs. Acute Med 2012;11:157–160.
  • Helander A, Beck O, Hägerkvist R, Hultén P. Identification of novel psychoactive drug use in Sweden based on laboratory analysis–initial experiences from the STRIDA project. Scand J Clin Lab Invest 2013;73:400–406.
  • Persson HE, Sjöberg GK, Haines JA, Pronczuk de Garbino J. Poisoning severity score. Grading of acute poisoning. J Toxicol Clin Toxicol 1998;36:205–213.
  • Bäckberg M, Beck O, Hultén P, Rosengren-Holmberg J, Helander A. Intoxications of the new psychoactive substance 5-(2-aminopropyl)indole (5-IT): A case series from the Swedish STRIDA project. Clin Toxicol (Phila) 2014;52:618–624.
  • Al-Saffar Y, Stephanson NN, Beck O. Multicomponent LC-MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine–experience from the Swedish population. J Chromatogr B Analyt Technol Biomed Life Sci 2013;930: 112–120.
  • Johansson M, Fransson D, Rundlöf T, Huynh NH, Arvidsson T. A general analytical platform and strategy in search for illegal drugs. J Pharm Biomed Anal 2014;100:215–229.
  • Helander A, Bäckberg M, Beck O. MT-45, a new psychoactive substance associated with hearing loss and unconsciousness. Clin Toxicol (Phila) 2014;52:901–904.
  • Kronstrand R, Roman M, Dahlgren M, Thelander G, Wikström M, Druid H. A cluster of deaths involving 5-(2-aminopropyl)indole (5-IT). J Anal Toxicol 2013;37:542–546.
  • Kronstrand R, Thelander G, Lindstedt D, Roman M, Kugelberg FC. Fatal intoxications associated with the designer opioid AH-7921. J Anal Toxicol 2014;38:599–604.
  • Dominici P, Kopec K, Manur R, Khalid A, Damiron K, Rowden A. Phencyclidine Intoxication Case Series Study. J Med Toxicol 2014. [Epub ahead of print]
  • Bluelight. Available at: http://www.bluelight.org/vb/content/. (Accessed on June, 2015)
  • Drug-Forum. Available at: https://drugs-forum.com/forum/index.php. (Accessed on June, 2015)
  • Erowid. Available at: http://www.erowid.org/. (Accessed on June, 2015)
  • Flashback. Available at: https://www.flashback.org. (Accessed on June, 2015)
  • EMCDDA. Risk assessments of a various psychoactive substances 1999–2015. Available at: http://www.emcdda.europa.eu/publications/searchresults?action = list&type = PUBLICATIONS&SERIES_PUB = w12. (Accessed on June, 2015)
  • EMCDDA. European Drug Report 2015: Trends and Developments. 2015. Available at: http://www.emcdda.europa.eu/publications/edr/trends-developments/2015 (Accessed on June, 2015)
  • Beck O, Rausberg L, Al-Saffar Y, Villen T, Karlsson L, Hansson T, et al. Detectability of new psychoactive substances, ‘legal highs’, in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse. Drug Test Anal 2014;6:492–499.
  • Reisfield GM, Goldberger BA, Bertholf RL.‘False-positive’ and ‘false-negative’ test results in clinical urine drug testing. Bioanalysis 2009;1:937–952.
  • Schwartz RH. Urine testing in the detection of drugs of abuse. Arch Intern Med 1988;148:2407–2412.
  • Davies S, Wood DM, Smith G, Button J, Ramsey J, Archer R, et al. Purchasing ‘legal highs’ on the Internet–is there consistency in what you get? QJM 2010;103:489–493.
  • Bäckberg M, Beck O, Jönsson K-H, Helander A. Opioid intoxications involving butyrfentanyl, 4-fluorobutyrfentanyl, and fentanyl from the Swedish STRIDA project. Clin Toxicol (Phila) 2015;53:609–617.
  • Läkemedelsverkets förteckning I över narkotika (LVFS 2014:11). [The Medical Products Agency's list of provisions on narcotics]. 2014. Available at: https://lakemedelsverket.se/upload/lvfs/LVFS_2014_11.pdf. (Accessed on June, 2015)
  • Stevenson R, Tuddenham L. Novel psychoactive substance intoxication resulting in attempted murder. J Forensic Leg Med 2014;25: 60–61.
  • Johansson A, Thelander G, Roman M, Lindstedt D, Sandler H, Rubertsson S, et al. Intoxications associated with the novel dissociative drug 3-MeO-PCP (abstract presented at the Nordic Conference on Forensic Medicine. Stockholm, Sweden, June 10–13, 2015).
  • Roth BL, Gibbons S, Arunotayanun W, Huang XP, Setola V, Treble R, et al. The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor. PLoS One 2013; 8:e59334.
  • Barton CH, Sterling ML, Vaziri ND. Phencyclidine intoxication: clinical experience in 27 cases confirmed by urine assay. Ann Emerg Med 1981;10:243–246.
  • Walberg CB, McCarron MM, Schulze BN. Quantitation of phencyclidine in serum by enzyme immunoassay: results in 405 patients. J Anal Toxicol 1983;7:106–110.
  • McCarron MM, Schulze BW, Thompson GA, Conder MC, Goetz WA. Acute phencyclidine intoxication: clinical patterns, complications, and treatment. Ann Emerg Med 1981;10:290–297.
  • Yago KB, Pitts FN Jr., Burgoyne RW, Aniline O, Yago LS, Pitts AF. The urban epidemic of phencyclidine (PCP) use: clinical and laboratory evidence from a public psychiatric hospital emergency service. J Clin Psychiatry 1981;42:193–196.
  • Bey T, Patel A. Phencyclidine intoxication and adverse effects: a clinical and pharmacological review of an illicit drug. Cal J Emerg Med 2007;8:9–14.
  • McCarron MM, Schulze BW, Thompson GA, Conder MC, Goetz WA. Acute phencyclidine intoxication: incidence of clinical findings in 1,000 cases. Ann Emerg Med 1981;10:237–242.
  • Zawilska JB. Methoxetamine–a novel recreational drug with potent hallucinogenic properties. Toxicol Lett 2014;230:402–407.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.